Skip to main content

Lupus

      Deucravacitinib (TYK2) data has been surprisngly good in SLE

      Strong rationale in PsA as well; I liked this poster &

      Mike Putman EBRheum

      1 year 10 months ago
      Deucravacitinib (TYK2) data has been surprisngly good in SLE Strong rationale in PsA as well; I liked this poster & the focus on pain scores / patient QOL Probably my #1 draft pick for "drugs I'm buying right now" @RheumNow #ACR23 Abstr0508 https://t.co/FHNvgUrYxp
      Tired of getting referrals for symptomatic patients with 1/80+ ANAs antibodies?

      This new risk model for systemic AID is

      Aurelie Najm

      1 year 10 months ago
      Tired of getting referrals for symptomatic patients with 1/80+ ANAs antibodies? This new risk model for systemic AID is very welcome! Variables: age, female, higher ANA titer, higher platelet count, disease-specific autoantibody & billing code count. #ACR23 @Rheumnow ABST0131 https://t.co/q8rYjjtZ89
      Year in Review: Dr. P Seo

      Dr. Seo gave a moment of silence to Baricitinib use in SLE given studies showing it is not e

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year 10 months ago
      Year in Review: Dr. P Seo Dr. Seo gave a moment of silence to Baricitinib use in SLE given studies showing it is not efficacious for SLE #ACR23 @RheumNow https://t.co/8GKUlfJdbe
      Thinking beyond immunosuppression for SLE Nephritis management:
      SGLT-2i
      GLP-1RA
      ERAs
      @RheumNow #ACR23 https://t.co/RdmKn

      Robert B Chao, MD

      1 year 10 months ago
      Thinking beyond immunosuppression for SLE Nephritis management: SGLT-2i GLP-1RA ERAs @RheumNow #ACR23 https://t.co/RdmKnm08YY
      Does knowing ischemic stroke subtypes among SLE patients matter?
      This study by Hopia et al 👉54% of ischemic strokes

      sheila

      1 year 10 months ago
      Does knowing ischemic stroke subtypes among SLE patients matter? This study by Hopia et al 👉54% of ischemic strokes in 56 SLE pts were APS/aPL & cardioembolic origin (accdg to TOAST) & +assoc with STAT4 gene. #ACR23 ABST0579 @RheumNow https://t.co/Ut8QPpQNQp
      SLE pts with +aCL IgG/IgM and LA had higher risk of developing atherosclerotic CVD accdg to this prospective study by Di

      sheila

      1 year 10 months ago
      SLE pts with +aCL IgG/IgM and LA had higher risk of developing atherosclerotic CVD accdg to this prospective study by Ding et al. . . . 🧐Again, SLE pts have ⬆️CV risk so always risk stratify and intervene early. #ACR23 ABST0552 @RheumNow https://t.co/QhttQZzp8G
      This study by Munoz-Grajales et al show that the analyte S100A8/A9 (highest AUC) was able to differentiate between SLE p

      sheila

      1 year 10 months ago
      This study by Munoz-Grajales et al show that the analyte S100A8/A9 (highest AUC) was able to differentiate between SLE pts with cognitive impairment and those without. . . . Interesting findings. More data needed to confirm and explain why it is so. #ACR23 ABST0558 @RheumNow https://t.co/LcF6s2qgNr
      Acute pregnancy-related CV event risk found to be highest in pts w/ SLE+ APS, followed by primary APS, and SLE w/ LN. Mo

      Dr. Rachel Tate

      1 year 10 months ago
      Acute pregnancy-related CV event risk found to be highest in pts w/ SLE+ APS, followed by primary APS, and SLE w/ LN. Most importantly, 25-30% of events happen post-partum! Monitor these pts carefully! #ACR23 Plenary 0722 #ACRbest https://t.co/yD5VFJ2SXh @rheumnow https://t.co/PDvzbs19fR
      For over 70 years, glucocorticoids, (GC) have been a part of standard therapy in SLE. They are classically used to not only induce remission or treat an acute flare, but also as maintenance therapy. They are a valuable 'friend' if used wisely, and can become a 'foe' if used excessively.
      Join us tonight at 6pm PT/ 9pm ET for our daily #ACR23 recap. https://t.co/0RDwTdzhwS

      Dr. John Cush RheumNow

      1 year 10 months ago
      Join us tonight at 6pm PT/ 9pm ET for our daily #ACR23 recap. https://t.co/0RDwTdzhwS
      ACR Convergence is truly drinking from the proverbial fire hose. It’s a beautiful mash-up of basic science and treatment updates meets guidelines, recommendations, and disease identification. My goal when attending any conference is to learn as much as I can, synthesize that information, and bring you clinically relevant morsels for you to consider for your practice. 
      Managing stress is a key in many autoimmune diseases. Do not forget non pharmacological techniques.
      @RheumNow #ACR23 ht

      Bella Mehta bella_mehta

      1 year 10 months ago
      Managing stress is a key in many autoimmune diseases. Do not forget non pharmacological techniques. @RheumNow #ACR23 https://t.co/pACxOSaN7A
      Pregnancy is complicated for women with rheumatic diseases.

      There's a pathway to healthy mothers & babies, but it t

      David Liew drdavidliew

      1 year 10 months ago
      Pregnancy is complicated for women with rheumatic diseases. There's a pathway to healthy mothers & babies, but it takes: - planning - the right meds - the right disease control. @drbags71 #ACR23 Review Course @RheumNow https://t.co/epdDIVGPye
      @drbags71 @RheumNow Too often we don't leave women of childbearing age with a plan, if they do get pregnant. And we need

      David Liew drdavidliew

      1 year 10 months ago
      @drbags71 @RheumNow Too often we don't leave women of childbearing age with a plan, if they do get pregnant. And we need to help them get ready, for whatever they want, so we can avoid bad outcomes - and all the consequences of that. @drbags71 #ACR23 Review COurse @RheumNow https://t.co/HLg6KjCiJX
      @drbags71 @RheumNow So approach @drbags71:

      HOP-STEP
      - proactively ask/communicate
      - make difficult discussions easier w

      David Liew drdavidliew

      1 year 10 months ago
      @drbags71 @RheumNow So approach @drbags71: HOP-STEP - proactively ask/communicate - make difficult discussions easier with these truly amazing guides: https://t.co/9AJIrF9bsQ counselling https://t.co/618mrifi3f dr/pt Rx plans ⬆️**bookmark these** - share do not miss! #ACR23 Review Course @RheumNow https://t.co/vWwJLu2HWG
      ×